1. Home
  2. MPAA vs ENTA Comparison

MPAA vs ENTA Comparison

Compare MPAA & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPAA
  • ENTA
  • Stock Information
  • Founded
  • MPAA 1968
  • ENTA 1995
  • Country
  • MPAA United States
  • ENTA United States
  • Employees
  • MPAA N/A
  • ENTA N/A
  • Industry
  • MPAA Auto Parts:O.E.M.
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MPAA Consumer Discretionary
  • ENTA Health Care
  • Exchange
  • MPAA Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • MPAA 154.5M
  • ENTA 154.0M
  • IPO Year
  • MPAA 1994
  • ENTA 2013
  • Fundamental
  • Price
  • MPAA $9.50
  • ENTA $5.59
  • Analyst Decision
  • MPAA
  • ENTA Buy
  • Analyst Count
  • MPAA 0
  • ENTA 4
  • Target Price
  • MPAA N/A
  • ENTA $17.25
  • AVG Volume (30 Days)
  • MPAA 130.3K
  • ENTA 228.9K
  • Earning Date
  • MPAA 02-10-2025
  • ENTA 05-05-2025
  • Dividend Yield
  • MPAA N/A
  • ENTA N/A
  • EPS Growth
  • MPAA N/A
  • ENTA N/A
  • EPS
  • MPAA N/A
  • ENTA N/A
  • Revenue
  • MPAA $753,727,000.00
  • ENTA $66,590,999.00
  • Revenue This Year
  • MPAA $7.30
  • ENTA N/A
  • Revenue Next Year
  • MPAA $5.96
  • ENTA N/A
  • P/E Ratio
  • MPAA N/A
  • ENTA N/A
  • Revenue Growth
  • MPAA 4.26
  • ENTA N/A
  • 52 Week Low
  • MPAA $4.36
  • ENTA $4.71
  • 52 Week High
  • MPAA $11.89
  • ENTA $17.80
  • Technical
  • Relative Strength Index (RSI)
  • MPAA 44.77
  • ENTA 31.66
  • Support Level
  • MPAA $9.07
  • ENTA $5.65
  • Resistance Level
  • MPAA $10.36
  • ENTA $5.96
  • Average True Range (ATR)
  • MPAA 0.65
  • ENTA 0.36
  • MACD
  • MPAA -0.24
  • ENTA -0.15
  • Stochastic Oscillator
  • MPAA 16.73
  • ENTA 4.77

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard parts in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: